Gefitinib and Celecoxib in Treating Patients With Refractory Non-Small Cell Lung Cancer
Clinical trial NCT00068653 · COMPLETED
Trial details
- NCT number
- NCT00068653
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Primary completion
- 2007-10-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.